UPSC Prelims Practice Questions — India Medtech Expo 2025 showcased End-To-End Medtech Ecosystem Reinforcing India’s Position as a Global Medtech Innovation Hub

Q1. Among the flagship pharma-MedTech schemes anchored at India MedTech Expo 2025, which one has the largest financial outlay?

  • A. PLI Scheme for Pharmaceuticals
  • B. PRIP (Promotion of Research & Innovation in Pharma-MedTech) Scheme
  • C. PLI Scheme for Bulk Drugs (KSMs/DIs/APIs)
  • D. Pradhan Mantri Bhartiya Janaushadhi Pariyojana (initial corpus)

Q2. With reference to the PRIP (Promotion of Research & Innovation in Pharma-MedTech) Scheme, consider the following statements. Which of the above is/are correctly identified?

  1. It was launched with a financial outlay of ₹5,000 crore.
  2. One of its components establishes Centres of Excellence at the NIPERs.
  3. It is administered by the Department of Health Research under the Ministry of Health & Family Welfare.
  4. It seeks to shift India's pharma-MedTech sector from cost-based to innovation-based growth.
  • A. 1, 2 and 4
  • B. 1 and 3
  • C. 2, 3 and 4
  • D. 1, 2, 3 and 4

Q3. In the context of the Department of Pharmaceuticals' initiatives, the acronym 'PRIP' stands for which one of the following?

  • A. Production and Research Incentive Programme
  • B. Promotion of Research and Innovation in Pharma-MedTech Sector
  • C. Pharmaceutical Research and Industrial Partnership
  • D. Priority Research and Innovation Package

Q4. The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) is operationalised through which one of the following implementing agencies?

  • A. National Pharmaceutical Pricing Authority (NPPA)
  • B. Central Drugs Standard Control Organisation (CDSCO)
  • C. Pharmaceuticals & Medical Devices Bureau of India (PMBI)
  • D. National Health Authority (NHA)

Q5. With reference to the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), consider the following statements. Which of the above is NOT correct?

  1. It was launched in the year 2008.
  2. Its medicines are dispensed through Janaushadhi Kendras.
  3. It functions under the Department of Pharmaceuticals.
  4. It supplies only patented branded formulations.
  • A. 1 only
  • B. 4 only
  • C. 2 and 3
  • D. 1 and 4

Q6. With reference to the evolution of the National Institutes of Pharmaceutical Education and Research (NIPERs), consider the following statements. Which of the statements given above is/are correct?

  1. The NIPER Act, 1998 initially provided for a single institute at S.A.S. Nagar (Mohali).
  2. The Act was amended in 2007 to permit establishment of similar institutes in other parts of the country.
  3. All NIPERs were declared Institutes of National Importance by the original NIPER Act of 1998.
  • A. 1 and 2 only
  • B. 1 and 3 only
  • C. 2 and 3 only
  • D. 1, 2 and 3

Q7. The designation 'Institute of National Importance', conferred on the NIPERs, primarily signifies that the institution—

  • A. is established or declared by an Act of Parliament and empowered to award its own degrees
  • B. is fully financed by the government of the State in which it is located
  • C. is a deemed-to-be university notified under University Grants Commission regulations
  • D. is a private autonomous body incorporated under the Companies Act

Q8. At India MedTech Expo 2025, how many breakthrough health technologies did the ICMR license to industry partners under its Medical Innovations–Patent Mitra initiative?

  • A. 7
  • B. 9
  • C. 11
  • D. 17

Q9. In the Department of Pharmaceuticals' year-end review, 191 of the 726 items reported as manufactured for the first time were 'KSMs'. In this context, 'KSM' refers to—

  • A. Key Starting Materials
  • B. Knowledge Sharing Modules
  • C. Key Sourcing Mechanisms
  • D. Kilogram Standard Measures

Q10. Consider the following programmes/institutions. Which of the above is/are correctly identified as administered by the Department of Pharmaceuticals?

  1. PLI Scheme for Pharmaceuticals
  2. Pradhan Mantri Bhartiya Janaushadhi Pariyojana
  3. National Institutes of Pharmaceutical Education and Research (NIPERs)
  4. Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (health insurance)
  • A. 1 and 4 only
  • B. 1, 2 and 3
  • C. 2 and 3 only
  • D. 1, 2, 3 and 4